Every FDA approval letter and released Complete Response Letter we hold, by FDA action date: FDA approval letters.
Questions
Was penpulimab-kcqx (penpulimab-kcqx) approved by the FDA?
Yes. The FDA approved the application for penpulimab-kcqx (penpulimab-kcqx) on April 23, 2025, per the FDA's own record. The primary source is linked on this page.
What was penpulimab-kcqx (penpulimab-kcqx) under FDA review for?
The application covered Nasopharyngeal carcinoma (recurrent/metastatic). The FDA approved the application on April 23, 2025.
How did ANTE stock react to the FDA decision?
On the decision day ANTE moved -14.1%. That is the recorded reaction to this specific event. Historical measurement, not a prediction, and not investment advice.